CS
KRON

Credit Suisse’s Kronos Bio KRON Stock Holding History

Credit Suisse’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2
Closed -$3 – 3527
2022
Q4 		$3 Sell
2
-229
-99% -$527 ﹤0.01% 3868
2022
Q3 		$1K Buy
231
+190
+463% +$858 ﹤0.01% 3871
2022
Q2 		$0 Sell
41
-12,385
-100% -$56.1K ﹤0.01% 4133
2022
Q1 		$89K Sell
12,426
-1,304
-9% -$11.1K ﹤0.01% 3485
2021
Q4 		$187K Sell
13,730
-23,529
-63% -$368K ﹤0.01% 4293
2021
Q3 		$780K Buy
37,259
+28,653
+333% +$616K ﹤0.01% 3525
2021
Q2 		$206K Buy
+8,606
New +$218K ﹤0.01% 4271

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Credit Suisse's KRON Position: Q1 2023 in Review

Credit Suisse sold out of Kronos Bio (KRON) in Q1 2023, closing a stake of 2 shares — an estimated $3 sold.

Credit Suisse first reported a position in KRON in Q2 2021 and held it in 7 quarters. The position peaked at $780K in Q3 2021. 87 funds tracked by Wall St. Rank hold KRON as of Q1 2023.

  • Credit Suisse reported no remaining Kronos Bio position as of Q1 2023 after selling out during the quarter.
  • Credit Suisse sold 2 Kronos Bio shares in Q1 2023, an estimated $3.
  • Credit Suisse first reported a position in Kronos Bio in Q2 2021 and held it in 7 quarters.
  • Credit Suisse's Kronos Bio position peaked at $780K in Q3 2021.
  • 87 funds tracked by Wall St. Rank held Kronos Bio as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.